Research Updates – from ALSA's National Office
for January 6, 2006

Evidence Published as to How Mutant Protein Acts in ALS

Mutant protein may leave cells to harm surrounding cells, according to published findings in an animal model of ALS that suggest new approaches to the disease’s treatment. Read full story>>

ALS/MND Meeting Heralds Paradigm Shift in Viewing ALS

More than 850 delegates attended the ALS/MND Alliance meeting in Dublin this past December. A steadily growing audience for the conference attests to the many researchers from all fields who are committed to a solution for motor neuron diseases, commented Lucie Bruijn, Ph.D., ALSA science director and vice president, who attended, as did Sharon Matland, R.N., MBA, ALSA’s vice president for patient services. Read full story>>

Entering 2006 with Renewed Hope: Progress in ALS Research

The turning of the year brings with it a renewal of hope for progress toward successful treatment for ALS, with numerous major advances during the past twelve months. In particular, 2005 saw the launch of a new initiative that is already bringing lab advances into the clinical arena. Read full story>>

Research Summary 2005: Advances Give Renewed Hope for the Coming Year

A recap of key findings published in 2005 that point the way toward new therapies for the nerve wasting disease, amyotrophic lateral sclerosis. Read full story>>

ALS Patients Can Contribute Blood Sample, Clinical History for Repository

ALS patients and interested relatives, spouses, or friends can now further the search for effective new treatment by providing a blood sample and clinical information that will be made available anonymously through a National Institutes of Health repository. Read full story>>